R&G PharmaStudies Dividends and Buybacks
Dividend criteria checks 2/6
R&G PharmaStudies is a dividend paying company with a current yield of 0.35% that is well covered by earnings.
Key information
0.3%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0.3% |
| Future Dividend Yield | 0.4% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.200 |
| Payout ratio | 13% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether 301333's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 301333's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| R&G PharmaStudies Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (301333) | 0.3% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Life Sciences) | 1.3% |
| Analyst forecast (301333) (up to 3 years) | 0.4% |
Notable Dividend: 301333's dividend (0.35%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 301333's dividend (0.35%) is low compared to the top 25% of dividend payers in the CN market (2.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (12.9%), 301333's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (12.7%), 301333's dividend payments are thoroughly covered by cash flows.